Published in

American Association for the Advancement of Science, Science, 6574(374), 2021

DOI: 10.1126/science.abl9551

Links

Tools

Export citation

Search in Google Scholar

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

Journal article published in 2021 by Joanne Watkins, Thushan I. de Silva, Gregory R. Young, Matthew Wyles, Mariateresa de Cesare, Eleri Wilson-Davies, Louis du Plessis, Danni Weldon, Ana da Silva Filipe, Chris Williams, Li Xu-Mccrae, Eric Witele, Ben Warne, Thomas Williams, Rachel J. Williams and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Vaccination and disease The United Kingdom has high rates of vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exceeding 80% of adults. As immunity wanes and social distancing is relaxed, how are rates of illness and severe disease affected by more infectious variants? Elliott et al . used reverse transcription PCR data from the REACT-1 study, which showed exponential transmission as the Alpha variant (B.1.1.7) was replaced by the Delta variant (B.1.617.2). After adjusting for age and other variables, vaccine effectiveness for the new variant averaged 55% in June and July of 2020. Despite the slower growth of the pandemic in the summer, it looks as if increased indoor mixing in the autumn will sustain transmission of the Delta variant despite high levels of adult vaccination. —CA